Although loss of SELENBP1 expression may be secondary to tumor development, the ability of SELENBP1 to inhibit cell proliferation and induce apoptosis in colon cancer [30] may suggest that the protein may also be involved in tumorigenesis of uterine leiomyoma. Here, SELENBP1 is linked to malignant colon neoplasm.